AG
IPSC icon

Algert Global’s Century Therapeutics IPSC Stock Holding History

Algert Global’s Portfolio IPSC Stock Details IPSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-76,800
Closed -$76K – 1247
2025
Q4 		$76K Buy
+76,800
New +$46.8K ﹤0.01% 1103

Other funds holding IPSC

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Algert Global's IPSC Position: Q1 2026 in Review

Algert Global sold out of Century Therapeutics (IPSC) in Q1 2026, closing a stake of 76,800 shares — an estimated $76K sold.

Algert Global first reported a position in IPSC in Q4 2025 and held it in 1 quarter. The position peaked at $76K in Q4 2025. 72 funds tracked by Wall St. Rank hold IPSC as of Q1 2026.

  • Algert Global reported no remaining Century Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Algert Global sold 76,800 Century Therapeutics shares in Q1 2026, an estimated $76K.
  • Algert Global first reported a position in Century Therapeutics in Q4 2025 and held it in 1 quarter.
  • Algert Global's Century Therapeutics position peaked at $76K in Q4 2025.
  • 72 funds tracked by Wall St. Rank held Century Therapeutics as of Q1 2026.

Based on Algert Global's 13F filing for Q1 2026, filed 14 May 2026.